MTAP and breast cancer: Furthermore, the result of log rank test showed that BC patients with low expression of MTAP (median survival time, 119 months) experienced a shorter overall survival (OS) than BC patients with high MTAP expression (median survival time, 125 months; P=0.0334, Figure 1E).